semaglutide lawsuit compounding Novo Nordisk protects US patients with legal wins against compounders, including ruling that permanently prohibits pharmacy from selling illegitimate, knockoff Wegovy® or Ozempic® How the FDA's Semaglutide Ruling

With Novo Holdings $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.

Tennis icon Serena Williams told TODAY why she started using GLP-1 medication to lose weight and what she tried previously

Prefilled Injection Pen

The expert group emphasized the importance of timely glycemic control, combination therapy, and targeting the underlying pathophysiology of T2DM

This guide covers timing of dose pauses, GI motility effects, bowel cleansing efficacy, and recovery protocols to help you prepare confidently

Results We included 3040 patients initiating treatment with GLP-1RA and 11,627 with SGLT-2i